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Abstract: Peptide based lectin mimetics represent an attractive approach for the development of artificial carbohydrate receptors that might 
find application in bio-analytical and medicinal fields. Taking into consideration the structure of typical lectin binding site, we have designed a 
novel artificial receptor molecule possessing a rigid three-dimensional structure, hydrogen-bonding site and lipophilic binding pocket to 
promote hydrophobic interaction and hydrogen-bonding. A new solid-phase synthetic approach that allows complete synthesis of desired 
bicyclic peptide 1 on the solid support was developed. CD spectra of peptides 1 and 2 indicate that the structure of 1 is rather rigid and 
preorganised for the three-dimensional monosaccharide substrates binding. The binding affinities of bicyclic peptide receptor 1 toward various 
carbohydrate substrates at physiologically relevant conditions were estimated by UV/vis and fluorimetric titration experiments, and the 
observed values are in the millimolar range. With these results we have demonstrated that the bicyclic peptide 1 represent a promising basis 
for the design of new and more efficient carbohydrate receptors that may have broader application in bio-analytical or medicinal field. 
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INTRODUCTION 
ARBOHYDRATE recognition is one of the most 
sophisticated recognition processes in biological 
systems.[1] This process mediates many important aspects 
of cell-cell recognition, such as inflammation, cell 
differentiation, tumor cell colonization and metastasis. 
However, due to its complexity and weak binding affinities, 
carbohydrate recognition by natural systems is still poorly 
understood. On the other hand, studies on synthetic carbo-
hydrate receptors could make significant contributions to a 
better understanding of this process and lead to the 
development of new agents for application in bio-analytical 
and medicinal fields. Considering the importance of the 
carbohydrate recognition, it is not surprising that design 
and synthesis of artificial receptors for these important 
biological substrates attracted a great deal of attention in 
biomimetic chemistry.[2] Current efforts are mainly focused 
on the design of receptors for complexation of mono- or 
disaccharides.[2a,3] This crude simplification has been based 
on the structural studies of the lectins, revealing that 
carbohydrate binding sites are typically shallow binding 
pockets where only binding of the terminal mono-
saccharide moieties can occur.[4] Binding of an individual 
lectin to monosaccharide substrate is extremely weak; the 
association constant (Ka) for these complexes are typically 
in the 10–4 – 10–2 mol–1dm3 range. Binding was achieved 
through a combination of hydrogen bonding to the 
monosaccharide hydroxyl groups and van der Waals 
packing of the hydrophobic sugar face against aromatic 
amino acid side chains forming sandwich-type inter-
actions.[4b,4d] Taking into consideration these binding prin-
ciples, a variety of receptors for monosaccharide binding in 
organic solvent have been prepared.[2a,3a] However, con-
struction of artificial receptors for binding of carbohydrates 
in water represent particularly challenging task, mainly due 
to the weak hydrogen-bonding interactions.  
 Carbohydrate binding protein mimicking molecules 
using the peptide-based systems (lectinomimics) represent 
particularly attractive approach for the development of 
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artificial carbohydrate receptors.[5] Given the number 
available L- and D-amino acid building blocks, even small 
peptides offer enormous diversity and potential for design 
and development of new, and more selective artificial 
carbohydrate receptors. Numerous efforts are underway to 
find carbohydrate specific peptides using the phage-display 
technique,[5a] or combinatorial chemistry.[5b] Importantly, 
these peptide based lectinomimics bind carbohydrate sub-
strates in aqueous media with the affinities comparable to 
those reported for lectin/monosaccharide complexes.[4b,4c] 
 Considering the structure of typical lectin binding site, 
we have designed a novel artificial receptor molecule pos-
sessing a rigid three-dimensional structure, hydrogen-bond-
ing site and lipophilic binding pocket to promote hydrophobic 
interaction and hydrogen-bonding. As a model system we 
chose a cyclic cationic peptide antibiotic polymyxin B 
(PMB),[6] which is known to bind the lipid A disaccharide 
moiety of lipopolysaccharide (LPS) with the high affinity.[7] 
 Herein, we report the design, synthesis and binding 
properties of polymyxin based bicyclic peptide 1, Scheme 
1, toward the various mono- and disaccharide substrates in 
aqueous media. 
 
MATERIALS AND METHODS 
Wang resin was purchased from Chem-Impex (Wood Dale, 
IL, USA) and Rink amide AM resin was purchased from 
Millipore-Sigma (Burlington, MA, USA). Fmoc-protected 
amino acids and coupling reagents (HOBt, HBTU, PyBOP) 
were purchased from Chem-Impex (Wood Dale, IL, USA).  
N-methylmorpholine, hydrazine, triethylamine and Pd(PPh3)4 
was purchased from Sigma Aldrich (St. Louis, MO, USA). All 
solvents were purchased from Fisher-Scientific (Waltham, 
MA USA), and were analytical reagent grade or better. 
Individual peptides were synthesized on a PS3 automated 
peptide synthesizer (Gyros Protein Technologies, Tucson, AZ, 
USA). Mass spectrometry was performed on MALDI-TOF 
Voyager-DE STR (Applied Biosystems, Foster City, CA, USA) 
in reflector mode using α-cyano-4-hydroxycinnamic acid as 
a matrix and positive mode. Analytical RP-HPLC analyses 
and peptide purifications were performed on 1260 Infinity 
(Agilent Technologies, Santa Clara, CA, USA) liquid 
chromatography systems equipped with a UV/Vis detector. 
CD spectra were recorded on a Jasco-810 spectro-
polarimeter (Jasco, Easton, MD). Titration experiments 
were performed on Varian Cary 3 UV/vis spectrophoto-
meter (Paolo Alto CA, USA) and Perkin Elmer LS50B 
Luminescence Spectrometer (Waltham, MA, USA). 
Peptide Synthesis 
All linear peptide precursors were synthesized in a 0.25 
mmol scale on the automated peptide synthesizer using 
standard Fmoc chemistry. The level of the Asp residue 
attachment to the resins was determined by the direct 
measurement of released dibenzofulvene after Fmoc 
deprotection using UV/vis spectroscopy.[8] ivDde, Mtt and 
Allyl protecting groups were removed according to the 
standard protocols.[9] Peptide cyclization was performed 
manually using PyBop/HOBt/NMM method over 10 h 
period. 2,2’-bipyridine-5,5'-dicarboxylic acid was coupled 
manually to Orn5 residue after ivDde removal using 
standard PyBop/HOBt/NMM method over 10 h, followed 
by Mtt removal from Orn3 residue and final macro-
cyclization using PyBop/HOBt/NMM method over 10 h. The 
resulting peptidyl resins were cleaved with a trifluoroacetic 
acid (TFA/TIS/CH2Cl2 (95:2.5:2.5). Synthesized peptides 
were purified by RP-HPLC (Phenomenex Jupiter C-18 column, 
250 × 21.2 mm, 300 Å pore size, 10 µm particle size) using 
a linear gradient (100 % A → 100 % B; A = 0.1 % TFA in H2O, 
B = 0.1 % TFA in MeCN:H2O = 9:1) and a flow rate of 7 
mL/min. Peptides purities were confirmed by analysis using 
analytical RP-HPLC (Grace Vydac C18 column, 250 × 4.6 mm, 
120 Å pore size, 5 µm particle size), and MALDI TOF mass 
spectrometry. For structural comparison, cyclic peptide 2 
possessing the same amino acid sequence as bicyclic 
peptide 1 was synthesized. 
Circular Dichroism Spectroscopy 
CD spectra were recorded in water using a quartz cell of 1 
mm optical path length. Spectra were measured over a 
wavelength range 180–250 nm with an instrument scan-
ning speed of 100 nm/min and a response time 1 s. The 
peptide concentrations were 1 mmol dm–3 for 1 and 1.2 
mmol dm–3 for 2, and the CD spectra are the result of eight 
averaged scans taken at 25 °C. All CD spectra are baseline-
corrected for signal contribution due to the water. CD 
spectra were modeled using the CDPro suite of programs 
employing SDP42 database.  
 
 
Figure 1. CD spectra of bicyclic peptide 1 (––––), and cyclic 
peptide 2 (- - -). 
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Scheme 1. Solid-phase synthesis of bicyclic peptide 1. 
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Fluorescence and UV/vis Titration 
Experiments 
Titration experiments were performed at room temper-
ature in aqueous sodium cacodylate buffer (50 mmol dm–3, 
pH = 6.5). In all experiments concentration of receptor 1 
was kept constant (creceptor = 2.5 × 10–5 mol dm–3 for fluori-
metric and creceptor = 5 × 10–5 mol dm–3 for UV/vis titrations), 
whereas the concentration of monosaccharide substrates 
was varied from cca 1 × 10–5 –4 × 10–2 mol dm–3 in the case 
of UV/vis and 1 × 10–5 –1 × 10–3 mmol dm–3 in the case of 
fluorimetric titration experiments. The association cons-
tants (log Ka) were calculated using the SPECFIT global 
analysis software.[8] The stoichiometry for complexes of 1 
with monosaccharides was determined by the mole ratio 
method (Job plot).[10] 
 
RESULTS AND DISCUSSION  
Bicyclic Peptide Design and  
Solid-phase Synthesis 
The conformationally constrained cage-like molecules, 
such as bicyclic peptide receptor 1, represent an interesting 
topology for designing artificial receptors capable of 
binding biologically important monosaccharides under 
physiological conditions. In this type of monosaccharide 
receptors, the three-dimensional lipophilic cavity is already 
preorganised for the three-dimensional monosaccharide 
substrates binding, meaning that there are less entropically 
unfavorable conformations formed in order to adopt the 
optimal complex geometry. In addition, incorporation of 
functionalities for hydrogen bonding interactions within 
receptor's three-dimensional structure will permit mono-
saccharide substrates not only to be complexed but to be 
encapsulated, allowing therefore monosaccharide binding 
in water. 
 Our synthetic receptor is modeled on cyclic 
decapeptide antibiotic polymyxin B.[6] Polymyxin B consists 
of a seven member ring containing four positively charged 
diaminobutyric acid (Dab) residues, one Thr residue, 
hydrophobic D-Phe and Leu residues, and the N-terminal 
lipophylic tail region composed of Dab-Thr-Dab-6-methyl-
octanoic acid segment. However, previous reports showed 
that polymyxin derivative lacking the side chain terminal 
fatty acyl diaminobutyrate, so called polymyxin B nona-
peptide or PMBN, can still bind LPS with relatively high 
affinity.[7a,11] The model of PMB/lipid A complex const-
ructed by docking of PMBN NMR structure on lipid A 
suggested that the polar face of PMB peptide ring interacts 
with the disaccharide part of lipid A.[7a] Quite interestingly, 
the PMBN analogue in which the Dab residues were 
replaced by Orn has been shown to bind strongly lipid A 
even after losing its antibacterial activity.[11c] Taking into 
consideration the structure of typical lectin binding site and 
above mentioned literature data, we based our peptide 
lectinomimic 1 on PMBN. In addition, since PMBN Orn 
analogue retains its binding affinity toward lipid A, and 
considering a greater selection of commercially available 
orthogonally protected Orn derivatives, we decided to 
incorporate Orn residues instead of Dab into the receptor’s 
peptide sequence, Scheme 1. 
 Solid-phase synthesis of PMB[12] and its truncated 
analogue PMBN[11b,11c] has been reported previously. 
Described synthetic paths include solid-phase assembly of 
linear precursors using standard Fmoc-chemistry, followed 
by peptide cyclization in solution, or synthesis using a 
safety-catch sulfonamide linker and peptide cyclization 
with associated cleavage from the solid support. However, 
the same synthetic strategies cannot be applied for the 
synthesis of peptide receptor 1 due to its structural 
complexity (i.e. required bicyclic structure formed by 
incorporation of the bipyridine dicarboxylate moiety). 
Therefore, we have developed a new solid-phase synthetic 
approach that allows complete synthesis of desired bicyclic 
peptide 1 on the solid support. In general, our synthetic 
approach toward bicyclic peptide 1 was comprised of the 
resin attachment of the Asp residue via side chain, 
successful use of combination of six quasi-orthogonal 
removable protecting groups, stepwise Fmoc solid-phase 
synthesis of a linear precursor, on-resin head-to-tail 
cyclization, and in the final step on-resin attachment of the 
bipyridine dicarboxylate moiety. Anchoring of the first 
residue to the resin is one of the most critical steps in 
peptide synthesis. Choice of a wrong linker, loading 
method, or amino acid can have highly deleterious effects 
on the purity of synthesized peptides. In order to optimize 
this first step, two different types of resins were used: the 
hydroxymethyl-based Wang resins (substitution 0.95 
mmol/g) yielding cyclic peptide with the C-terminal 
carboxylate moiety, and the aminomethyl-based Rink 
resins (substitution 0.43 mmol/g) yielding corresponding 
analogue with the C-terminal amide moiety. The level of 
the Asp residue attachment to the resins was determined 
by the spectroscopic (UV/vis) method as previously 
described in the literature.[8] The best results were 
obtained with the Rink amide resins (yields 75 % –80 %). 
The Fmoc chemistry was used throughout the linear 
peptidyl-resin precursor synthesis. After removal of C-
terminal Allyl protecting group and N-terminal Fmoc 
protecting groups using standard deprotection methods,[9] 
linear peptide precursor was successfully cyclized on resin 
using PyBop/HOBt/NMM as we previously described.[13] 
Incorporation of bipyridine unit into peptide skeleton 
represented additional challenging synthetic task. For this 
purpose, Orn residues with ivDde protected side chain’s 
amino groups were used. ivDde side chain protected Orn 
was chosen because ivDde can be removed by hydrazine 
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reagent without affecting remaining protecting groups 
present on the peptide. In this way, we have generated two 
primary amino groups available for incorporation of the 
bipyridine dicarboxylate bridge. It was expected that 
coupling of bipyridine dicarboxylate under pseudo-dilution 
conditions[14] will result exclusively in the desired bicyclic 
peptide 1. However, after deprotection of Orn side chain 
amino groups with 2 % hydrazine in DMF and sub-
sequential coupling of 1 eq of 2,2’-bipyridine-5,5’-dicarb-
oxylic acid only undesired cyclic peptide 3 bearing two 
bipyridine dicarboxylate units was obtained (MALDI-TOF 
MS analysis: m/z = 1270 calculated; m/z = 1292 [M+Na]+ 
observed), Scheme 1. This problem was solved by 
incorporating into the peptide precursor Orn residues with 
orthogonally protected side chain’s amino groups. For this 
purpose, we chose Fmoc-Orn(Mtt)-OH and Fmoc-
Orn(ivDde)-OH to incorporate in positions 2 and 5, respec-
tively, of the cyclic peptidyl-resin precursor sequence. 
Selective removal of ivDde protecting group with 2 % 
hydrazine in DMF allowed incorporation of only one 2,2’-
bipyridine-5,5’-dicarboxylic acid moiety. In the next step, 
Mtt protecting group was removed with 1 % TFA in CH2Cl2, 
followed by on-resin macrocyclization using PyBop/NMM. 
Progress and completion of the coupling reaction and 
macrocyclization was monitored by the ninhydrin 
colorimetric test.[15] Cleavage of the resulting bicyclic pep-
tide product from the resins was carried out in 95 % of 
trifluoroacetic acid (TFA)/CH2Cl2 mixture in the presence of 
triisopropylsilane (TIS) as a scavenger. This time desired 
peptide 1 was synthesized in satisfactory yield (85 %, 
MALDI-TOF MS analysis: m/z = 1026.15 calculated; m/z = 
1026.45 observed. RP-HPLC analysis: Rt = 23.2 min., linear 
gradient 100 % A → 100 % B in 30 min. at flow rate of 1 
mL/min. As shown in Scheme 1, control cyclic peptide 2 was 
synthesized using the same solid-phase synthetic strategy 
(yield 90 %, MALDI-TOF MS analysis: m/z = 817,98, 
calculated; m/z = 818.41 [M+H]+, 840.44 [M+Na]+ observed. 
RP-HPLC analysis: Rt = 20.18 min., linear gradient 100 % A 
→ 100 % B in 40 min. at flow rate of 1 mL/min. 
Conformational Characterization by  
CD Spectroscopy 
Since the receptor preorganization plays a key role in the 
complexation process, we investigated an effect of 
bipyridine dicarboxylate bridge on receptor’s conformation 
by CD spectroscopy. The CD spectra were recorded in 
cacodylate buffer (pH = 6.5, 50 mmol dm–3). In both cases, 
the spectra minimums were obtained at λ = 196 nm 
characteristic of unordered peptide conformations, indic-
ating absence of peptide conformational changes upon 
incorporation of the bipyridine bridge. In comparison to the 
control peptide 2, the observed more pronounced negative 
band at λ = 223 and positive band at λ = 212 nm for bicyclic 
peptide 1 can be interpreted as a contribution of aromatic 
bipyridine bridge to the CD spectrum rather than the 
consequence of conformational change.[16] Obtained 
results are in good agreement with previously published CD 
data for PMBN also showing unordered conformation in 
aqueous solution.[11b,11c] However, previously reported 1H 
NMR studies[17] suggested that conformation of free PMBN 
in aqueous solution is characterized by a type II’ β-turn 
centered on the Dab5-D-Phe6-Leu7-Dab8 sequence and an 
inverse γ-turn at Thr10. Based on our results and results of 
others, we can assume that receptor 1 has a rigid solution 
conformation and expect no significant conformational 
changes upon monosaccharide substrate binding, minimiz-
ing therefore the entropic penalty of binding.  
Binding Studies 
Our preliminary binding studies indicate that the bicyclic 
peptide lectinomimic 1 is capable of binding monosac-
charides with millimolar affinities in aqueous media. The 
binding affinities of bicyclic peptide 1 toward various 
monosaccharide substrates in cacodylate buffer (pH = 6.5, 
Table 1. Association constants for 1 : 1 complexes between various carbohydrate substrates and 1 in aqueous media (pH = 6.5) 
Carbohydrate substrates 
log Ka 
Fluorimetric titration UV/Vis titration 
Ribose 3.1 ± 0.21 3.45 ± 0.15 
Xylose 3.8 ± 0.2 3.17 ± 0.05 
Glucose 3.48 ± 0.15 2.96 ± 0.15 
Galactose 3.67 ± 0.15 3.36 ± 0.05 
Fructose 3.31 ± 0.1 2.85 ± 0.07 
Glucose-6-phosphate 3.27 ± 0.09 3.11 ± 0.19 
N-Acetylmuramic acid 3.21 ± 0.13 3.2 ± 0.13 
Gentiobiose ND ND 
ND=not determinable under applied experimental conditions 
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50 mmol dm–3) were estimated by UV/vis and fluorimetric 
titration experiments, and the observed values are shown 
in Table 1. The association constants (log Ka) were 
calculated using the SPECFIT global analysis software.[8] In 
all cases, a reasonably good agreement between the two 
methods was obtained. The stoichiometry for complexes of 
1 with monosaccharides was determined by the mole ratio 
method (Job plot)[10] to be 1:1, Figure 2. As shown in Table 
1, the selectivity of the peptide based receptor 1 with 
respect to a specific monosaccharide is, at best, modest. On 
another hand, affinity toward larger substrate such as 
gentiobiose, a disaccharide composed of two D-glucose 
units, are much lower and thus not determinable by 
fluorescence or UV/vis titration experiments under the 
same experimental conditions. The observed 1 : 1 
stoichiometry for complexes of 1 with monosaccharide 
substrates and weak interaction with larger disaccharide 
substrate indicate that complexation occurs by insertion of 
the substrate molecule into receptor’s lipophilic pocket, 
mimicking therefore similar process in lectins. The fact that 
the association constants for negatively charged mono- 
saccharides are identical, within an experimental error, to 
those found for the neutral substrates suggests a signif-
icant contribution of hydrophobic interactions to the 
overall complex stability. Importantly, estimated assoc-
iation constants are similar to those reported in the 
literature for lectin/monosaccharide complexes, proving 
further our designing principle for the bio-mimetic 
monosaccharide receptors containing the three-dimens-
ional lipophilic cavity. 
 
CONCLUSION 
Despite the lack of bicyclic peptide 1 selectivity toward 
various monosaccharide substrates, our binding studies 
successfully demonstrated that it is possible to construct 
peptide-based artificial receptor molecules capable of 
binding biologically important carbohydrates at phys-
iologically relevant conditions. The design of this bio-
mimetic receptor is based on the premises that the 
receptor molecule should be soluble in water, should 
possess a three-dimensional intermolecular binding site 
into which the three-dimensional monosaccharide sub-
strates may be inserted, and that the conformation of the 
receptor molecule should be restricted to reduce the 
entropic penalty of binding.  
 With these results, we have also demonstrated that 
the bicyclic peptide 1 represents a promising scaffold for 
the design of new and more efficient carbohydrate 
receptors that may have broader application in bio-
analytical field. Further optimization of bicyclic peptide 
receptor 1 using combinatorial chemistry approach is 
currently underway in order to improve its binding 
properties and selectivity. 
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Figure 2. The Job plot indicating 1:1 stoichiometry for the 
complex between 1 and galactose. 
 
 
Figure 3. Representative titration experimant. (a) UV/vis titration of 1 with galactose (cgalactose = 0.1–1.46 mmol dm–3); (b) 
Experimantal (○) and calculated (  ̶) absorbancies (λmax.= 295 nm) as a function of added galactose. 
(a)                                                                            (b) 
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Abbreviations 
TFA ................... Trifluoroacetic acid 
PyBop ............... Benzotriazol-1-yl-oxytripyrrolidinophosphonium 
hexafluorophosphate 
HOBt ................ Hydroxybenzotriazole  
NMM ............... N-methylmorpholine 
Fmoc ................ 9-Fluorenylmethyloxycarbonyl protecting group 
ivDde ................ 1-(4,4-Dimethyl-2,6-dioxo-cyclohexylidene)-3-
methyl-butyl protecting group 
Mtt ................... 4-Methyltrityl protecting group 
DMF ................. N,N-dimethylformamide 
TIS .................... Triisopropylsilane 
RP-HPLC ........... Reverse phase-high performance liquid chromato-
graphy 
MALDI-TOF ...... Matrix-assisted laser desorption/ionisation-time of 
flight mass spectrometry 
NMR ................. Nuclear magnetic resonance spectroscopy 
CD .................... Circular dichroism spectroscopy 
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